TNSR (Tensor) 24-hour amplitude 42.0%: Strong rebound from the low of $0.0362 driven by increased trading volume
Bitget Pulse2026/04/09 07:15Volatility Overview
In the past 24 hours, TNSR price rebounded from a low of $0.0362 to a high of $0.0514, currently quoted at $0.05079, with a fluctuation of 42.0%, presenting an overall V-shaped rebound trend. The 24-hour trading volume is approximately $5.4 million, slightly down from the previous day but still active; on-chain net inflows are around $24,000 (dominated by net outflows from CEX, with minor inflows on DEX).
Brief Analysis of Unusual Movements
- No official announcements or mainstream news events have directly driven the price in the past 24 hours.
- On-chain data shows small net inflows (about $24,000), with no significant whale transfers recorded.
- The price rebounded from the $0.0343-$0.036 support zone, accompanied by increased trading volume, possibly led by technical buying.
Market View and Outlook
The dominant sentiment in the community remains bullish, with X platform TA discussions focusing on the stability of the $0.0358-$0.036 support, with potential upside above $0.041. However, caution is advised regarding RSI overbought risk and supply resistance above; in the short term, if the $0.036 low is lost, a retest of lower demand areas is possible.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, and is for information reference only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Rising Demand for Weight Loss Drugs Drives Eli Lilly's Q2 Revenue Up 48% Year-on-Year, Full-Year Revenue Guidance Raised to $85-87 Billion｜Earnings Report Insights
Eli Lilly's Q2 revenue reached $22.97 billion, a year-on-year increase of 48%. Adjusted EPS was significantly above expectations, and the company simultaneously raised its full-year guidance. Surging demand for weight loss and diabetes medications has made the GLP-1 business the core driver of growth, boosting profitability. With the advancement of next-generation weight loss therapies and the expansion of its innovative pipeline, Eli Lilly is accelerating the development of a diversified growth engine.
After a sharp drop, Sandisk (SNDK.US) rises for two consecutive days—can the financial report confirm the start of an AI storage comeback?
Judging from history, after SanDisk's financial report was released and the stock price plummeted, it seemed to provide a good opportunity for dip buyers.
U.S. Tech Stocks Stage Major Comeback! Earnings Season Rekindles AI Faith, Nasdaq 100 Market Cap Surges $3.5 Trillion in Four Days
After strong earnings reports boosted investor confidence in the prospects of artificial intelligence (AI), U.S. technology stocks experienced a dramatic reversal, driving the Nasdaq 100 Index's market value to increase by $3.5 trillion in just four trading days.
TRON’s 15 billion milestone meets fading buy pressure – Can TRX’s $0.332 fall?
Crypto prices
More
